Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Nektar Therapeutics (NKTR +6.7%) gets a lift after saying it will present positive...

  • Wednesday, September 21, 2011, 12:16 PM ET
    Nektar Therapeutics (NKTR +6.7%) gets a lift after saying it will present positive proof-of-concept data from its first Phase 1 clinical trial of NKTR-181 at the American Academy of Pain Management's 22nd Annual Clinical Meeting.
Track new comments on this story

This news story has 1 comment:

  •  
    Good, I'm long NKTR.
    21 Sep 2011, 01:13 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »